These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 4961042)

  • 41. Tuberculous meningitis due to primary drug-resistant Mycobacterium tuberculosis hominis.
    Bonforte RJ; Karpas CM; Gribetz I; Shanzer S
    Pediatrics; 1968 Dec; 42(6):969-75. PubMed ID: 4973145
    [No Abstract]   [Full Text] [Related]  

  • 42. [Comparative results of treatment of pulmonary tuberculosis with the compounds of benzoyl-PAS-Ca-isoniazide and streptomycin-isoniazid].
    Favez G; Gonin JD; Gubéran E; de Kalbermatten JP; Vulliémoz P; Willa C
    Schweiz Med Wochenschr; 1969 Feb; 99(5):150-6. PubMed ID: 4974643
    [No Abstract]   [Full Text] [Related]  

  • 43. Results of one-year chemotherapy with isoniazid (INH), streptomycin (SM) and ethionamide (ETA) in previously untreated patients with cavernous pulmonary tuberculosis.
    Zajaczkowska J; Krychniak W; Krakówka P; Buraczewska M
    Pol Med J; 1966; 5(2):339-44. PubMed ID: 5915720
    [No Abstract]   [Full Text] [Related]  

  • 44. Primary drug-resistant tuberculosis in active-duty military personnel: 1959-1968.
    Briney RR; Cowley RG
    Am Rev Respir Dis; 1970 May; 101(5):700-2. PubMed ID: 4986424
    [No Abstract]   [Full Text] [Related]  

  • 45. [On the practical value of tuberculosis resistance tests].
    Klein G; Primer G
    Prax Pneumol; 1969 Jan; 23(1):17-22. PubMed ID: 4978558
    [No Abstract]   [Full Text] [Related]  

  • 46. Controlled comparison of oral twice-weekly and oral daily isoniazid plus PAS in newly diagnosed pulmonary tuberculosis.
    Br Med J; 1973 Apr; 2(5857):7-11. PubMed ID: 4633061
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Rifampicin with ethambutol for drug-resistant tuberculosis.
    Pines A
    Br J Dis Chest; 1971 Jul; 65():178-81. PubMed ID: 4997816
    [No Abstract]   [Full Text] [Related]  

  • 48. Capreomycin compared with streptomycin in original treatment of pulmonary tuberculosis. XVI. A report of the Veterans Administration-Armed Forces Cooperative. Study on the Chemotherapy of Tuberculosis.
    Schwartz W
    Am Rev Respir Dis; 1966 Dec; 94(6):858-64. PubMed ID: 4958888
    [No Abstract]   [Full Text] [Related]  

  • 49. A continuing survey of primary drug resistance in tuberculosis, 1961 to 1968. A U.S. Public Health Service cooperative study.
    Doster B; Caras GJ; Snider DE
    Am Rev Respir Dis; 1976 Apr; 113(4):419-25. PubMed ID: 817629
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Comparison between SM daily and twice weekly treatment in the regimen of SM, INH and PAS--particularly considering the degree of drug resistance-- (report 1) (author's transl)].
    Baba H; Azuma Y
    Kekkaku; 1975 Jul; 50(7):191-7. PubMed ID: 810615
    [No Abstract]   [Full Text] [Related]  

  • 51. [Primary resistance to the major antitubercular drugs in pulmonary tuberculosis patients during 1961-1966].
    Jaroszewicz W; Buraczewska M; Pichulowa K; Pszonicka A; Zych D
    Gruzlica; 1968; 37(1):17-21. PubMed ID: 5720034
    [No Abstract]   [Full Text] [Related]  

  • 52. A controlled clinical trial of the drug treatment of new cases of pulmonary tuberculosis.
    Böszörményi M; Schweiger O
    Scand J Respir Dis Suppl; 1968; 65():189-93. PubMed ID: 4978460
    [No Abstract]   [Full Text] [Related]  

  • 53. Bacteriological aspects of mycobacterial infections.
    Mitchison DA
    Br Med J; 1972 Feb; 1(5797):424-5. PubMed ID: 4621657
    [No Abstract]   [Full Text] [Related]  

  • 54. Primary drug resistance: a continuing study of drug resistance in tuberculosis in a veteran population within the United States. V. September 1963 to September 1965.
    Hobby GL; Johnson PM; Crawford-Gagliardi L; Boytar V; Johnson GE
    Am Rev Respir Dis; 1966 Nov; 94(5):703-8. PubMed ID: 4958840
    [No Abstract]   [Full Text] [Related]  

  • 55. Treatment of patients with pulmonary tuberculosis classified according to the history of previous chemotherapy and without reference to pre-treatment drug sensitivity.
    de Figueiredo FP
    Tubercle; 1969 Dec; 50(4):335-43. PubMed ID: 5367209
    [No Abstract]   [Full Text] [Related]  

  • 56. [Clinical significance of the resistance to the classical tuberculostatics].
    Eule H
    Z Tuberk Erkr Thoraxorg; 1965 Jul; 123(4):319-24. PubMed ID: 5897859
    [No Abstract]   [Full Text] [Related]  

  • 57. Comparison of single and divided daily dosages of isoniazid and PAS in the treatment of pulmonary tuberculosis. XV. A report of the Veterans Administration-Armed Forces Cooperative. Study on the chemotherapy of tuberculosis.
    Reisner D
    Am Rev Respir Dis; 1966 Dec; 94(6):849-57. PubMed ID: 4958797
    [No Abstract]   [Full Text] [Related]  

  • 58. The effect of isoniazid in one daily dose.
    Brander L; Selroos O
    Acta Tuberc Pneumol Scand; 1965; 46(3):191-6. PubMed ID: 4956375
    [No Abstract]   [Full Text] [Related]  

  • 59. [Primary resistance in adult pulmonary tuberculosis in France. 3d report of the study center on Primary Resistance: 1966-1970].
    Canetti G; Le Lirzin M; Gay P; Thibier R; Kreis B; Grosset J
    Rev Tuberc Pneumol (Paris); 1972; 36(3):337-56. PubMed ID: 5080965
    [No Abstract]   [Full Text] [Related]  

  • 60. Progress of tuberculous diabetes coming under supervision during the years 1953-65 up to July 1972.
    Ross JD
    Tubercle; 1973 Jun; 54(2):130-40. PubMed ID: 4203158
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.